DIVERSITY, EQUITY, AND INCLUSION
The ATS encourages diversity, equity, and inclusion for its journal authors, editors, and reviewers. This is especially important for those groups that have been historically under-represented in these areas. Bringing in diverse perspectives across disciplines, training levels, and identities has the potential to broaden the applicability and reach of our mission and activities and is known to improve overall scientific rigor and quality.
Latest Articles
The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America have updated clinical practice guidelines for TB treatment in children and adults in low-incidence settings without significant resource limitations.
JANUARY 2025 AJRCCM
Single-cell omics represent a paradigm shift in the study of PH, moving from a macroscopic view of organ-level changes to a microscopic view of cellular-level dynamics. In this review, the authors explore how advancements in scRNA-seq have enriched our understanding of different cellular compartments, dramatically enhancing our grasp of cellular dynamics, transitions, and the complex pathologies of PH at a cutting-edge level.
JANUARY 2025 AJRCMB
This study provides important supportive evidence for telerehabilitation as a cost-effective alternative model of pulmonary rehabilitation for people with chronic respiratory disease, with implications for clinical care, policy development, and future research to make pulmonary rehabilitation available to more people who could benefit.
January 2025 AnnalsATS
The multidisciplinary group of authors of this clinical practice guideline analyzed recent and relevant data to address the potential mortality benefit from the use of different antifungal strategies in two distinct clinical scenarios.
JANUARY 2025 AJRCCM
-
Wucherpfennig et al.Published Online: Mar 2024
CME
- Detecting Alpha-1 Antitrypsin Deficiency: Current State, Impediments, Opportunities, and Future Directions
StollerJanuary 2025AnnalsATS
- Access to Treatment for Chronic Obstructive Pulmonary Disease in the Americas: A Call for Action. A Joint Perspective from the Brazilian Thoracic Society, Canadian Thoracic Society, Latin American Thoracic Society, and the American Thoracic Society
Polverino et al.November 2024AnnalsATS
- The Management of Mild Pulmonary Hypertension in Clinical Practice
Zeder et al.August 2024AnnalsATS
- Management of Respiratory Failure in Hemorrhagic Shock
Davis et al.July 2024AnnalsATS
- Lung Disease and Social Justice: Chronic Obstructive Pulmonary Disease as a Manifestation of Structural Violence
Williams et al.April 15, 2024AJRCCM
In the News
- Risk for Cardiovascular Events Stays High 1 Year After COPD Exacerbation
HealioJanuary 22, 2025AJRCCM - HIV Lung Function Outcomes: Greater Risk for Impairments and Declining Function
Infectious Disease AdvisorJanuary 21, 2025AnnalsATS
- New Guidelines Recommend Shorter, All-Oral Regimens For Drug-Susceptible And Drug-Resistant Tuberculosis
Medical DialoguesJanuary 16, 2025ATS
- Monoclonal Antibodies in Eosinophilic COPD Safely Reduce Exacerbations
Pulmonology AdvisorJanuary 14, 2025AnnalsATS